Results
115
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
115 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
5TX | US$5.10 | -1.9% | 107.5% | US$96.4m | US$9.25 | PE14.5x | E20.8% | n/a | ||
XMS | US$0.56 | 20.2% | -46.7% | US$92.9m | US$1.96 | PB2.1x | E70.3% | n/a | ||
MN2 | SEK 2.42 | -1.6% | -16.3% | SEK 708.3m | SEK 4.16 | PS2.5x | E73.8% | 0% | ||
4GV | UK£0.56 | 0.9% | -39.7% | UK£51.9m | UK£1.09 | PB0.5x | E118.5% | 0% | ||
6FK | NOK 3.68 | -4.2% | 4.8% | NOK 663.2m | NOK 5.73 | PS4.3x | E45.3% | n/a | ||
L97 | HK$0.086 | 29.1% | -77.9% | HK$425.2m | n/a | PB0.5x | E113.6% | 0% | ||
6Y1 | SEK 2.36 | -2.5% | -2.1% | SEK 519.8m | SEK 5.50 | PS4.7x | E84.0% | n/a | ||
43 | US$6.10 | 10.9% | 10.9% | US$43.5m | US$20.88 | PS2x | E68.9% | n/a | ||
8BD | SEK 0.74 | 1.6% | -6.9% | SEK 341.0m | n/a | PE16.1x | E36.9% | 0% | ||
5NX | €4.07 | 16.6% | 51.3% | €29.0m | €3.23 | PS3.1x | E71.3% | n/a | ||
TTX | CA$0.093 | 0.5% | -34.5% | CA$41.3m | n/a | PS44.8x | E71.9% | n/a | ||
2300 | US$1.02 | -5.6% | 60.6% | US$25.9m | US$5.31 | PS1.4x | E71.2% | n/a | ||
G3O | €3.83 | -0.5% | 55.7% | €19.0m | €6.10 | PE17.9x | E35.2% | n/a | ||
AOHA | UK£0.10 | -2.8% | -26.8% | UK£7.4m | n/a | PS3.4x | E98.2% | n/a | ||
HY11 | US$1.87 | 0% | -83.3% | US$8.4m | US$32.08 | PB0.5x | E64.5% | n/a | ||
3KT | SEK 0.18 | 2.8% | 2.2% | SEK 76.3m | n/a | PE43.6x | E85.4% | n/a | ||
S1K | US$0.74 | 0% | n/a | US$5.2m | US$2.84 | PS3x | E72.4% | n/a | ||
26H | US$5.40 | 0% | -55.7% | US$3.7m | US$139.37 | PS4.6x | E69.6% | n/a | ||
E1Z | US$0.22 | -21.1% | n/a | US$2.2m | US$4.48 | PS1.5x | E147.0% | n/a |